Gossamer Bio, Inc. (GOSS)
10.26
-0.44
(-4.11%)
USD |
NASDAQ |
Sep 15, 16:00
10.22
-0.04
(-0.39%)
After-Hours: 17:22
Gossamer Bio Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 28, 2025 | 8.990 |
| March 27, 2025 | 8.913 |
| March 26, 2025 | 9.067 |
| March 25, 2025 | 9.835 |
| March 24, 2025 | 9.835 |
| March 21, 2025 | 10.68 |
| March 20, 2025 | 10.37 |
| March 19, 2025 | 10.45 |
| March 18, 2025 | 10.91 |
| March 17, 2025 | 10.68 |
| March 14, 2025 | 11.14 |
| March 13, 2025 | 9.989 |
| March 12, 2025 | 10.30 |
| March 11, 2025 | 9.374 |
| March 10, 2025 | 8.836 |
| March 07, 2025 | 9.297 |
| March 06, 2025 | 9.374 |
| March 05, 2025 | 9.067 |
| March 04, 2025 | 8.683 |
| March 03, 2025 | 9.067 |
| February 28, 2025 | 9.451 |
| February 27, 2025 | 9.144 |
| February 26, 2025 | 9.989 |
| February 25, 2025 | 9.682 |
| February 24, 2025 | 9.989 |
| Date | Value |
|---|---|
| February 21, 2025 | 10.76 |
| February 20, 2025 | 11.76 |
| February 19, 2025 | 10.91 |
| February 18, 2025 | 10.60 |
| February 14, 2025 | 10.07 |
| February 13, 2025 | 10.07 |
| February 12, 2025 | 9.758 |
| February 11, 2025 | 9.528 |
| February 10, 2025 | 8.990 |
| February 07, 2025 | 8.145 |
| February 06, 2025 | 8.529 |
| February 05, 2025 | 8.836 |
| February 04, 2025 | 7.837 |
| February 03, 2025 | 7.914 |
| January 31, 2025 | 7.634 |
| January 30, 2025 | 7.405 |
| January 29, 2025 | 7.058 |
| January 28, 2025 | 7.075 |
| January 27, 2025 | 7.021 |
| January 24, 2025 | 7.146 |
| January 23, 2025 | 6.807 |
| January 22, 2025 | 6.931 |
| January 21, 2025 | 7.084 |
| January 17, 2025 | 7.391 |
| January 16, 2025 | 7.684 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| United Therapeutics Corp. | 3.336 |
| Arbutus Biopharma Corp. | 3.861 |
| Kura Oncology, Inc. | 20.76 |
| ACADIA Pharmaceuticals, Inc. | 3.527 |
| Alnylam Pharmaceuticals, Inc. | 23.54 |
Price to Book Value Related Metrics
| PS Ratio | 0.6122 |
| PEG Ratio | -0.0134 |
| Price | 10.26 |
| Earnings Yield | -542.5% |
| Market Cap | 62.69M |
| PEGY Ratio | -0.0134 |